Breaking News, Collaborations & Alliances

Univercells, Repligen Partner to Integrate Real-Time Monitoring Capabilities

Aim to enhance the development and manufacturing of viral vectors and vaccines.

Author Image

By: Charlie Sternberg

Associate Editor

Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, has partnered with Repligen Corporation to integrate real-time monitoring capabilities and enhance the development and manufacturing of viral vectors and vaccines. Repligen’s MAVEN Real Time Glucose Control Platform will be used to perform real-time monitoring of glucose and lactate in the range of scale-X bioreactors for adherent cell culture processes. The MAVEN is designed to mon...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters